00 · Headline Stats
Biopsy reimbursement
Up to 5x

MRI-guided vs. TRUS biopsy (CPT 55713 & 55715 vs. 55707)

Treatment reimbursement
Up to 7x

In-office treatment vs. hospital/ASC

Private payer upside
Up to 2x

Incremental revenue with private payers beyond Medicare rates

01 · Voices

My Promaxo MRI procedure was so easy and less invasive compared to a traditional biopsy.

Promaxo Patient
Promaxo Patient

In my community urology practice, the straightforwardness of Promaxo's MRI-guided transperineal biopsy workflow has empowered me to precisely target lesions, resulting in an impressive 77% cancer detection rate, ultimately making a significant impact on my patients' well-being.

Dr. James K. Bennett
Dr. James K. Bennett
Midtown Urology

I cannot thank my urologist and oncologist enough. Their careful care has added years of good health to my life.

Promaxo Patient
Promaxo Patient
02 · Install Footprint

Designed for the point of care.

Small footprint. Single-sided form factor. Fits through regular doorways and elevators. No cryogens, no RF-shielded rooms, no hospital-scale infrastructure. Quiet operation for improved patient comfort.

Field strength
0.06 T (low-field)
Shielding
No RF or magnetic shielding required
Footprint
Clinic setting compatible
Service contract
Varying levels of support available to customize to your needs.

Detailed install specs, site assessments, and timelines available on request. Global system install base.

03 · Who Uses Promaxo

ASCs.
Private practices.
Academic institutions.

01
Independent Practices

5x per biopsy. Run MR-guided procedures alongside clinic. Offer treatment in-office for the first time.

02
Ambulatory Surgery Centers

Leverage the shift from hospital to ASC. Better clinical outcomes. Increased reimbursement from new bundled codes.

03
Hospitals & Academic Centers

Higher tumor detection rate. More comprehensive and targeted treatment plans. Contained footprint — clinic, ASC, and OR settings.

04 · Economic Pillars

The math behind higher ROIs.
What it means for your practice.

⚠ Regulatory Clearance

*Screening is not yet cleared for commercial use.

01 · Biopsy
Up to 5x

MRI-Guided Biopsy Reimbursement

Urologists can currently use CPT 55707 for an ultrasound-guided biopsy. Under CMS 2026 guidelines, Promaxo can enable billing of CPT (55713 & 55715) or (55714 & 55715) and from MR imaging codes (72195, 76376, 77021).

02 · Treatment
Up to 7x

In-Office Treatment Revenue

Promaxo brings targeted prostate treatment to point of care.*

03 · Ownership
In-Office

Complete Revenue Capture

Promaxo enables live MRI guidance directly in the physician office. All biopsy, imaging, and treatment revenue can stay within the practice.

04 · Volume
5 Patient Touchpoints

Full Patient Pathway In-House

Screening*, biopsy, treatment, imaging, and follow-up — Promaxo captures the entire patient care continuum under one roof.

The economics speak for themselves. See them live.